Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases?

Nir Lubezky, Ravit Geva, Einat Shmueli, Richard Nakache, Joseph M. Klausner, Arie Figer, Menahem Ben-Haim*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases?'. Together they form a unique fingerprint.

Medicine & Life Sciences